Catalyst Watch: Earnings Deluge, Farnborough Airshow, Paris Olympics, and Trump Talks Crypto
How To Earn $500 A Month From American Express Stock Ahead Of Q2 Earnings
American Express Company (NYSE:AXP) will release its second-quarter financial results, before the opening bell on Friday, July 19.Analysts expect the New York-based company to report quarterly
How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q2 Earnings
Johnson & Johnson (NYSE:JNJ) will release its second-quarter financial results, before the opening bell on Wednesday, July 17.Analysts expect the New Brunswick, New Jersey-based company to report
Emergent Biosolutions Grants Equity Award to Key Executive
Johnson & Johnson Faces MedTech Challenges But Is 'On Track' to Meet 2024 Guidance, Goldman Says
U.S. pharma giant Johnson & Johnson (NYSE:JNJ) will report its second-quarter 2024 earnings on Wednesday, July 17.As per data from Benzinga Pro, analysts estimate sales of $22.29 billion and
Emergent BioSolutions Secures $250M in Government Contract, Announces Strategic Moves Including Sale Of Baltimore Site to Boost Cash Generation and Slash Debt by $100M
Emergent BioSolutions Inc. (NYSE:EBS) today highlights several recent advancements in improving its financial health, marked by robust cash generation and meaningful debt repayment. As set forth in
Emergent BioSolutions Continues to Drive Improved Financial Position as Part of Multi-Year Transformation Plan
GAITHERSBURG, Md., July 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today highlights several recent advancements in improving its financial health, marked by robust cash generation and meaningful
Express News | On Monday, Johnson & Johnson Agreed To Pay $50M To Settle Claims Related To A Terminated Manufacturing Deal With Emergent BioSolutions Related To Johnson & Johnson's Covid-19 Vaccine - 8K
Emergent Biosolutions, Johnson & Johnson Settle Dispute Over COVID-19 Vaccine Manufacturing
Emergent Biosolutions (EBS) said in a regulatory filing Monday that its subsidiary, Emergent Manufacturing Operations Baltimore, and Johnson & Johnson's Janssen Pharmaceuticals unit have agreed to settle all disputes related to a manufacturing services agreement for Johnson & Johnson's COVID-19 vaccine.
Express News | Emergent BioSolutions- Deal to Resolve Claims From Manufacturing Services Deal for J&J's Investigational Sars-Cov-2 Vaccine, Ad26.cov2-S, Recombinant
Express News | Emergent BioSolutions Inc: Pursuant to Terms of Settlement Agreement, Janssen Will Pay Co $50 Mln on or Before July 31, 2024
Express News | Emergent BioSolutions - on July 3, Co, Unit, and Janssen Pharmaceuticals, Executed a Confidential Settlement Agreement and Release
Why Is Vaccine Maker Emergent BioSolutions Stock Trading Higher On Tuesday? (UPDATED)
Express News | Emergent Biosolutions Shares Are Trading Higher After the Company Announced It Has Received More Than $250 Million in Contract Modifications From the Administration for Strategic Preparedness and Response at the Department of Health and Human Services
Emergent Biosolutions Secures Major Vaccine Contracts With U.S.
Express News | Emergent BioSolutions Receives Over $250M In Contract Modifications From The HHS Administration For Strategic Preparedness And Response
Express News | Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government With Four Critical Medical Countermeasure Products
Express News | Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target
Benchmark Co. Maintains Emergent BioSolutions(EBS.US) With Buy Rating, Maintains Target Price $8
Benchmark Co. analyst Robert Wasserman maintains $Emergent BioSolutions(EBS.US)$ with a buy rating, and maintains the target price at $8.According to TipRanks data, the analyst has a success rate of 3
What Is Going On With Emergent BioSolutions Shares?
Emergent BioSolutions (NYSE:EBS) stock is trading higher on Thursday after the company announced the sale of its facility in Baltimore-Camden to Bora Pharmaceuticals.What Happened: On Thursday prior t